5634 related articles for article (PubMed ID: 3930068)
1. Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.
Kleinerman ES; Wiltrout RH; Zicht R; Fidler IJ
Cancer Immunol Immunother; 1985; 20(2):151-7. PubMed ID: 3930068
[TBL] [Abstract][Full Text] [Related]
2. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
5. Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.
Kleinerman ES; Ceccorulli LM; Zwelling LA; Twilley T; Herberman RB; Jacob J; Gelmann EP
J Clin Oncol; 1985 Jul; 3(7):1005-12. PubMed ID: 3926955
[TBL] [Abstract][Full Text] [Related]
6. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
7. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada A; Gray PW; Rinderknecht E; Schreiber RD
J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
[TBL] [Abstract][Full Text] [Related]
9. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic.
Kleinschmidt WJ; Schultz RM
J Interferon Res; 1982; 2(2):291-9. PubMed ID: 6811671
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
Sanders KM; Littman BH
J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma.
Le J; Vilcek J
Cell Immunol; 1984 Apr; 85(1):278-83. PubMed ID: 6424948
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma-induced production of monocyte cytotoxic factor.
Kildahl-Andersen O; Espevik T; Nissen-Meyer J
Cell Immunol; 1985 Oct; 95(2):392-406. PubMed ID: 3930074
[TBL] [Abstract][Full Text] [Related]
14. Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
Kleinerman ES; Fogler WE; Fidler IJ
J Leukoc Biol; 1985 May; 37(5):571-84. PubMed ID: 3920339
[TBL] [Abstract][Full Text] [Related]
15. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
16. Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
Kleinerman ES; Schroit AJ; Fogler WE; Fidler IJ
J Clin Invest; 1983 Jul; 72(1):304-15. PubMed ID: 6348087
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
18. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
[TBL] [Abstract][Full Text] [Related]
20. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]